RBI
ATRA icon

Raiffeisen Bank International’s Atara Biotherapeutics ATRA Stock Holding History

Raiffeisen Bank International’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$2.3K – 821
2025
Q2 		$1.54K Hold
200
– – ﹤0.01% 576
2025
Q1 		$1.19K Buy
+200
New +$1.75K ﹤0.01% 591

Other funds holding ATRA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raiffeisen Bank International's ATRA Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Atara Biotherapeutics (ATRA) in Q3 2025, closing a stake of 200 shares — an estimated $2.3K sold.

Raiffeisen Bank International first reported a position in ATRA in Q1 2025 and held it in 2 quarters. The position peaked at $1.54K in Q2 2025. 37 funds tracked by Wall St. Rank hold ATRA as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Atara Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 200 Atara Biotherapeutics shares in Q3 2025, an estimated $2.3K.
  • Raiffeisen Bank International first reported a position in Atara Biotherapeutics in Q1 2025 and held it in 2 quarters.
  • Raiffeisen Bank International's Atara Biotherapeutics position peaked at $1.54K in Q2 2025.
  • 37 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.